about
Plasma endothelin-1 levels in patients with systemic sclerosis: influence of pulmonary or systemic arterial hypertension.Rapid increase in plasma endothelin concentrations during percutaneous balloon dilatation of the mitral valve in patients with mitral stenosis.Insights into pathogenesis and treatment of cytokines in cardiomyopathy.Endothelin in cardiovascular control: the role of endothelin antagonists.Increased production of nitric oxide in coronary arteries during congestive heart failure.The therapeutic potential of endothelin receptor antagonists in cardiovascular disease.The role of endothelin in the pathogenesis of heart failure.Role of endothelins in congestive heart failure.A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunctionTherapeutic potential for endothelin receptor antagonists in cardiovascular disorders.Endothelins: pathophysiology and treatment implications in chronic heart failure.Angiotensin converting enzyme inhibition modulates endogenous endothelin in chronic canine thoracic inferior vena caval constriction.Myocardial protective effect of tezosentan, an endothelin receptor antagonist, for ischemia-reperfusion injury in experimental heart failure models.Cardioprotective signaling by endothelinRenin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure.Targeting the ROS-HIF-1-endothelin axis as a therapeutic approach for the treatment of obstructive sleep apnea-related cardiovascular complications.Role of endothelin-1 in mediating changes in cardiac sympathetic nerve activity in heart failure.Endothelin and vasoactive peptides: new cardiovascular mediators.Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension.A novel pharmacological action of ET-1 to prevent the cytotoxicity of doxorubicin in cardiomyocytes.Early activation of cardiac and renal endothelin systems in experimental heart failure.Endothelin-1 mediates cardiac mast cell degranulation, matrix metalloproteinase activation, and myocardial remodeling in rats.Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin.Endothelins: a possible mechanism of cytostatics-induced cardiomyopathy.Effects of NKH477 on endothelin-1-induced renal responses in anaesthetized dogs.Evidence for impaired endothelium dependent vasodilation in experimental left ventricular dysfunction.Effects of chronic heart failure on skeletal muscle capillary hemodynamics at rest and during contractions.Cigarette smoke exacerbates ventricular remodeling and dysfunction in the volume overloaded heart.Endothelin-1 prolongs intracellular calcium transient decay in neonatal rat cardiac myocytes.Inhibition by calcium antagonism of circulating and renal endothelin in experimental congestive heart failure.
P2860
Q33578329-A537C19E-8BAE-4126-93A8-A031E21871C4Q33612615-1A767ABE-B819-4E17-B093-352B54958104Q34027444-7B4835AE-8B72-4DB0-931A-4530EDBAEF31Q34028145-B8F843C6-CC55-41A4-ACE0-0E64B993A772Q34119551-F99C3137-8358-4EFF-8B71-5CB5ED7EF60EQ34317655-C0DBFE64-DE56-40A0-BE93-18F4DA4DB4F4Q34605378-ACD44ABA-BAF9-4C24-84F8-BC1E196A1CF2Q35168419-F87B000D-4A85-4D18-A2AC-E10F0BC4ABB4Q35552979-CD8428B8-4A9B-4720-BDFD-5D4F10A0E8A1Q35631333-F0CD6E7C-5C3B-4B8F-981A-7D06885CD859Q36332869-FB51B2F5-E6F5-427E-B277-067D5000362CQ37352635-8BEBCCD5-5A9C-433F-B610-967C259E7F73Q37364486-F24C8B27-7DCD-45A6-994F-FA8F1B891D87Q37397982-25A02AB8-996E-4064-8D0A-C2ADAE78FDD4Q37694008-022B767C-A373-40F1-A10A-9A7B430D7E81Q38919168-0E849CE0-5837-4DE9-BA9F-08979511F021Q40430494-39BDA363-97EB-4AD2-87BD-6643F21E0FBEQ40500962-135FC546-C0F9-4F83-8E15-5AF1F59790A3Q42249359-4340B285-65D9-48EA-A0ED-2B7ECE673D72Q43569485-032FEF7F-0FA9-4853-9F18-CB1F9FEDC45BQ44653196-EBB98B94-B24E-4061-90B3-F4BBFF55E1A7Q44961805-BA637738-E6CF-4368-86A8-DBCD7F722C6DQ46736643-D8D36B0F-EAB4-4968-AE1D-184C198B521BQ47722890-1B98DAFC-C1AE-44ED-BDF8-E25AB52389A3Q51393715-EC198C69-234A-4C66-82B0-6D0D3DB53F31Q51626826-43EFAEF0-439E-44E7-B51D-51E9F522DAC6Q52017015-3E460419-CCF6-4488-9595-77D3823215D8Q52619245-F7A9E2BB-ACAC-47C6-84CF-BAA127517951Q53258146-50E108B5-62E6-40AD-B761-D39C704C2F2BQ54064822-311BD1DE-A8B5-4867-A4A3-22450C614C8B
P2860
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Increased endothelin in experimental heart failure.
@en
type
label
Increased endothelin in experimental heart failure.
@en
prefLabel
Increased endothelin in experimental heart failure.
@en
P2093
P356
P1433
P1476
Increased endothelin in experimental heart failure.
@en
P2093
Burnett JC Jr
Hildebrand FL Jr
Margulies KB
Perrella MA
P304
P356
10.1161/01.CIR.82.6.2226
P407
P577
1990-12-01T00:00:00Z